NEW YORK (GenomeWeb News) — Luminex has licensed from The Johns Hopkins University genetic markers that it plans to use with its Tag-It cystic fibrosis test kits.
Luminex said the tests are available through its Molecular Diagnostics division, which was formerly Tm Bioscience. Luminex bought and renamed Tm Bio in March.
The non-exclusive agreement enables the company to use the IP in kits sold in the US. The license cover four mutations — 549N, 551D, 553X, and 559T — tested in the kit and two mutations, 553X and 551D, that appear in the screening panel of 23 cystic fibrosis mutations recommended by the American College of Medical Genetics and the American College of Obstetrics and Gynecology.
Financial terms of the agreement were not released.